Jason Gerberry

Stock Analyst at B of A Securities

(3.73)
# 768
Out of 5,044 analysts
162
Total ratings
57.76%
Success rate
5.13%
Average return

Stocks Rated by Jason Gerberry

Ionis Pharmaceuticals
Sep 23, 2025
Maintains: Buy
Price Target: $81$83
Current: $72.99
Upside: +13.71%
Amphastar Pharmaceuticals
Aug 26, 2025
Maintains: Neutral
Price Target: $28$32
Current: $24.04
Upside: +33.11%
Immunovant
Aug 12, 2025
Maintains: Buy
Price Target: $33$30
Current: $21.43
Upside: +39.99%
Biohaven
Aug 12, 2025
Maintains: Buy
Price Target: $50$49
Current: $17.39
Upside: +181.77%
Axsome Therapeutics
Aug 5, 2025
Maintains: Buy
Price Target: $173$176
Current: $134.68
Upside: +30.68%
ProKidney
Jun 30, 2025
Downgrades: Underperform
Price Target: $3$1
Current: $3.22
Upside: -68.94%
Liquidia
Jun 11, 2025
Maintains: Buy
Price Target: $25$23
Current: $22.76
Upside: +1.05%
Exelixis
Jun 5, 2025
Maintains: Neutral
Price Target: $45$46
Current: $39.99
Upside: +15.03%
Teva Pharmaceutical Industries
May 8, 2025
Maintains: Buy
Price Target: $20$22
Current: $19.61
Upside: +12.19%
Vaxcyte
Apr 1, 2025
Maintains: Buy
Price Target: $157$137
Current: $44.57
Upside: +207.38%
Maintains: Underperform
Price Target: $11$10
Current: $10.42
Upside: -4.03%
Reiterates: Buy
Price Target: $30
Current: $21.39
Upside: +40.25%
Maintains: Buy
Price Target: $84$100
Current: $86.70
Upside: +15.34%
Maintains: Buy
Price Target: $20$24
Current: $7.38
Upside: +225.20%
Maintains: Buy
Price Target: $21$20
Current: $21.56
Upside: -7.21%
Downgrades: Underperform
Price Target: $41$31
Current: $31.00
Upside: -
Maintains: Buy
Price Target: $600$550
Current: $6.03
Upside: +9,021.06%
Maintains: Neutral
Price Target: $27$29
Current: $29.72
Upside: -2.42%
Maintains: Buy
Price Target: $29$37
Current: $39.48
Upside: -6.28%
Maintains: Buy
Price Target: $52$56
Current: $41.89
Upside: +33.68%
Downgrades: Underperform
Price Target: $30
Current: $30.11
Upside: -0.37%
Maintains: Buy
Price Target: $204$217
Current: $139.33
Upside: +55.75%
Downgrades: Underperform
Price Target: $100$50
Current: $10.94
Upside: +357.04%
Maintains: Buy
Price Target: $450$500
Current: $826.41
Upside: -39.50%
Downgrades: Underperform
Price Target: $9
Current: $1.23
Upside: +631.71%
Downgrades: Underperform
Price Target: $37$25
Current: $7.06
Upside: +254.11%
Downgrades: Underperform
Price Target: $45$5
Current: $1.87
Upside: +167.38%
Downgrades: Underperform
Price Target: $27
Current: $6.20
Upside: +335.48%
Initiates: Neutral
Price Target: $20
Current: $1.60
Upside: +1,150.00%
Downgrades: Neutral
Price Target: $170$100
Current: $3.76
Upside: +2,559.57%
Reinstates: Neutral
Price Target: $95
Current: $228.03
Upside: -58.34%
Reinstates: Buy
Price Target: $60
Current: $43.39
Upside: +38.28%
Reinstates: Neutral
Price Target: $37
Current: $24.77
Upside: +49.37%
Reinstates: Neutral
Price Target: $90
Current: $88.00
Upside: +2.27%